Your browser doesn't support javascript.
loading
Combination therapy with anti-HIV-1 antibodies maintains viral suppression.
Mendoza, Pilar; Gruell, Henning; Nogueira, Lilian; Pai, Joy A; Butler, Allison L; Millard, Katrina; Lehmann, Clara; Suárez, Isabelle; Oliveira, Thiago Y; Lorenzi, Julio C C; Cohen, Yehuda Z; Wyen, Christoph; Kümmerle, Tim; Karagounis, Theodora; Lu, Ching-Lan; Handl, Lisa; Unson-O'Brien, Cecilia; Patel, Roshni; Ruping, Carola; Schlotz, Maike; Witmer-Pack, Maggi; Shimeliovich, Irina; Kremer, Gisela; Thomas, Eleonore; Seaton, Kelly E; Horowitz, Jill; West, Anthony P; Bjorkman, Pamela J; Tomaras, Georgia D; Gulick, Roy M; Pfeifer, Nico; Fätkenheuer, Gerd; Seaman, Michael S; Klein, Florian; Caskey, Marina; Nussenzweig, Michel C.
Afiliación
  • Mendoza P; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.
  • Gruell H; Laboratory of Experimental Immunology, Institute of Virology, University Hospital Cologne, Cologne, Germany.
  • Nogueira L; Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany.
  • Pai JA; German Center for Infection Research, partner site Bonn-Cologne, Cologne, Germany.
  • Butler AL; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.
  • Millard K; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.
  • Lehmann C; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.
  • Suárez I; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.
  • Oliveira TY; Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany.
  • Lorenzi JCC; German Center for Infection Research, partner site Bonn-Cologne, Cologne, Germany.
  • Cohen YZ; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
  • Wyen C; Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany.
  • Kümmerle T; German Center for Infection Research, partner site Bonn-Cologne, Cologne, Germany.
  • Karagounis T; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
  • Lu CL; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.
  • Handl L; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.
  • Unson-O'Brien C; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.
  • Patel R; Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany.
  • Ruping C; Praxis am Ebertplatz, Cologne, Germany.
  • Schlotz M; Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany.
  • Witmer-Pack M; Praxis am Ebertplatz, Cologne, Germany.
  • Shimeliovich I; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.
  • Kremer G; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.
  • Thomas E; Methods in Medical Informatics, Department of Computer Science, University of Tübingen, Tübingen, Germany.
  • Seaton KE; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.
  • Horowitz J; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.
  • West AP; Laboratory of Experimental Immunology, Institute of Virology, University Hospital Cologne, Cologne, Germany.
  • Bjorkman PJ; Laboratory of Experimental Immunology, Institute of Virology, University Hospital Cologne, Cologne, Germany.
  • Tomaras GD; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.
  • Gulick RM; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.
  • Pfeifer N; Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany.
  • Fätkenheuer G; Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany.
  • Seaman MS; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.
  • Klein F; Laboratory of Molecular Immunology, The Rockefeller University, New York, NY, USA.
  • Caskey M; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
  • Nussenzweig MC; Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
Nature ; 561(7724): 479-484, 2018 09.
Article en En | MEDLINE | ID: mdl-30258136
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Anticuerpos Anti-VIH / Infecciones por VIH / VIH-1 / Latencia del Virus / Anticuerpos Neutralizantes / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Idioma: En Revista: Nature Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Anticuerpos Anti-VIH / Infecciones por VIH / VIH-1 / Latencia del Virus / Anticuerpos Neutralizantes / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials Idioma: En Revista: Nature Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos